Your browser doesn't support javascript.
loading
Assessing anti-SARS-CoV-2 cellular immunity in 571 vaccines by using an IFN-γ release assay.
Wakui, Masatoshi; Uwamino, Yoshifumi; Yatabe, Yoko; Nakagawa, Terumichi; Sakai, Akiko; Kurafuji, Toshinobu; Shibata, Ayako; Tomita, Yukari; Noguchi, Masayo; Tanabe, Akiko; Arai, Tomoko; Ohno, Akemi; Yokota, Hiromitsu; Uno, Shunsuke; Yamasawa, Wakako; Sato, Yasunori; Ikeda, Mari; Yoshimura, Akihiko; Hasegawa, Naoki; Saya, Hideyuki; Murata, Mitsuru.
Afiliación
  • Wakui M; Department of Laboratory Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
  • Uwamino Y; Department of Laboratory Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
  • Yatabe Y; Department of Infectious Diseases, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
  • Nakagawa T; Clinical Laboratory, Keio University Hospital, Shinjuku-ku, Tokyo, Japan.
  • Sakai A; Clinical Laboratory, Keio University Hospital, Shinjuku-ku, Tokyo, Japan.
  • Kurafuji T; Clinical Laboratory, Keio University Hospital, Shinjuku-ku, Tokyo, Japan.
  • Shibata A; Clinical Laboratory, Keio University Hospital, Shinjuku-ku, Tokyo, Japan.
  • Tomita Y; Department of Laboratory Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
  • Noguchi M; Department of Laboratory Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
  • Tanabe A; Clinical Laboratory, Keio University Hospital, Shinjuku-ku, Tokyo, Japan.
  • Arai T; Clinical Laboratory, Keio University Hospital, Shinjuku-ku, Tokyo, Japan.
  • Ohno A; Clinical Laboratory, Keio University Hospital, Shinjuku-ku, Tokyo, Japan.
  • Yokota H; Clinical Laboratory, Keio University Hospital, Shinjuku-ku, Tokyo, Japan.
  • Uno S; Clinical Laboratory, Keio University Hospital, Shinjuku-ku, Tokyo, Japan.
  • Yamasawa W; Department of Infectious Diseases, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
  • Sato Y; Department of Laboratory Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
  • Ikeda M; Department of Epidemiology and Preventive Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
  • Yoshimura A; Department of Microbiology and Immunology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
  • Hasegawa N; Department of Microbiology and Immunology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
  • Saya H; Department of Infectious Diseases, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
  • Murata M; Division of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
Eur J Immunol ; 52(12): 1961-1971, 2022 12.
Article en En | MEDLINE | ID: mdl-36250411
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Límite: Humans Idioma: En Revista: Eur J Immunol Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Límite: Humans Idioma: En Revista: Eur J Immunol Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Alemania